Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Adma Biologics Inc (NASDAQ: ADMA) closed at $20.19 in the last session, up 2.54% from day before closing price of $19.69. In other words, the price has increased by $2.54 from its previous closing price. On the day, 2.4 million shares were traded.
Ratios:
We take a closer look at ADMA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 67.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 53.18. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 6.58. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when Grossman Adam S sold 21,000 shares for $19.45 per share. The transaction valued at 408,450 led to the insider holds 2,049,850 shares of the business.
Grossman Adam S sold 21,000 shares of ADMA for $450,660 on Apr 15 ’25. The President and CEO now owns 2,055,850 shares after completing the transaction at $21.46 per share. On Mar 19 ’25, another insider, Grossman Adam S, who serves as the President and CEO of the company, sold 21,000 shares for $18.92 each. As a result, the insider received 397,320 and left with 2,061,850 shares of the company.
Valuation Measures:
As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.92, and their Forward P/E ratio for the next fiscal year is 20.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.49 while its Price-to-Book (P/B) ratio in mrq is 12.90.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $25.67, while it has fallen to a 52-week low of $8.91. The 50-Day Moving Average of the stock is -1.03%, while the 200-Day Moving Average is calculated to be 9.95%.
Shares Statistics:
A total of 238.53M shares are outstanding, with a floating share count of 230.39M. Insiders hold about 3.49% of the company’s shares, while institutions hold 86.25% stake in the company.
